Insulet Corporation Announces Pricing of Secondary Public Offering BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced the pricing of its public offering of 4,898,398 shares
Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, announced plans to release its financial
Insulet Corporation Announces Proposed Secondary Public Offering of Common Stock BEDFORD, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, announced today that it has filed a registration statement
Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program BEDFORD, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the maker of the OmniPod ® Insulin Management System, today announced that it has been awarded a home medical
Insulet Corporation to Present at the William Blair Small Cap Growth Conference on October 3, 2007 BEDFORD, Mass., Sept. 26 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that Duane DeSisto,
BEDFORD, Mass., Aug. 29 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod ® Insulin Management System, today announced that Duane DeSisto, Chief Executive Officer, will participate in the Thomas Weisel Partners Healthcare Conference. Mr.
Insulet Corporation to Report Second Quarter 2007 Financial Results on Tuesday, August 14th BEDFORD, Mass., July 26, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer of the OmniPod Insulin Management System, announced plans to release its
Insulet Reports First Quarter 2007 Results BEDFORD, Mass., June 21 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod Insulin Management System, today announced financial results for its first quarter ended March 31, 2007.
Insulet Corporation to Report First Quarter 2007 Financial Results on Thursday, June 21st BEDFORD, Mass., June 12 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer of the OmniPod Insulin Management System, announced plans to release its financial results for the first
OCEANSIDE, Calif. - June 12, 2007 - When a cycling team of eleven Type 1 diabetics step onto their bikes for their second 3,043-mile Race Across America again this week, they'll be able to concentrate on another win - not insulin injections and blood glucose monitoring.
Insulet Corporation Announces Pricing of Initial Public Offering BEDFORD, Mass., May 15, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Insulet Corporation, (Nasdaq: PODD) today announced the pricing of its initial public offering of 7,700,000 shares of common stock at $15.00 per share.
Insulet Corporation Announces Proposed Initial Public Offering of Common Stock BEDFORD, MA, April 30, 2007— Insulet Corporation (“Insulet”) announced today that it has filed a registration statement relating to its proposed underwritten initial public offering of 6,700,000 shares of its common
Steven T. Sobieski Joins Insulet Corporation’s Board of Directors BEDFORD, Mass., February 20, 2007 – Steven T. Sobieski, Vice President, Finance & Administration and Chief Financial Officer of LifeCell Corporation, has joined the Board of Directors of Insulet Corporation.
